The Department for Business and Trade (DBT) Japan is hosting the fourth reverse pitch webinar, inviting speakers from pre-clinical stage R&D / Business Development from the leading six Japanese pharmaceutical companies: Astellas Pharma Inc, Daiichi Sankyo Co Ltd, Eisai Co Ltd, Mitsubishi Tanabe Pharma Corporation, Shionogi & Co Ltd and Takeda Pharmaceutical Company Limited.

This webinar, open to UK headquartered companies and universities, provides the ideal opportunity to learn the latest research priorities and collaboration structures of the leading Japanese pharmaceutical companies. There is an opportunity to set up 1-2-1 online calls with the companies at a later date on request.

You can register here